Global Nuclear Medicine Preclinical Imaging Equipment Market

Nuclear Medicine Preclinical Imaging Equipment Comprehensive Study by Application (Oncology, Cardiology, Neurology, Thyroid), Diagnostics (SPECT (Standalone, SPECT/CT System, SPECT/MRI System), PET (Standalone, PET/CT System, PET/MRI System), Trimodality (Spect/PET/CT) Systems), Therapeutics (Alpha Emitters (RA-223, Others), Beta Emitters (I-131, Y-90, SM-153, Re-186, Lu-117, Others), Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others)) Players and Region - Global Market Outlook to 2027

Nuclear Medicine Preclinical Imaging Equipment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Nuclear Medicine Preclinical Imaging Equipment
The global Nuclear Medicine Preclinical Imaging Equipment market is withness to grow in the forecasted period due to growing diagnostic applications in various diseases including cancer and cardiovascular diseases, government support, and shift from standalone to hybrid modalities. Nuclear medicine imaging is a method of producing images by detecting radiation from different parts of the body after a radioactive tracer is given to the patient. There is various equipment used for Nuclear Medicine Preclinical Imaging such as SPECT, PET. This technique can be used for the imaging of lung cancer, lymphoma, head and neck tumors, breast cancer, esophageal cancer, colorectal cancer, and urinary tract tumors. Hence, all the aforementioned technological advancements are expected to drive growth in this segment of the market studied, over the forecast period.

AttributesDetails
Study Period2017-2027
Base Year2021
High Growth MarketAsia Pacific
UnitValue (USD Million)


Analyst at AMA Research estimates that European Players will contribute the maximum growth to Global Nuclear Medicine Preclinical Imaging Equipment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Siemens AG (Germany), Bruker BioSpin (United States), Toshiba (Japan), Aspect Imaging (Israel), Trifoil Imaging (United States), MILabs (Netherlands), Mediso Medical Imaging Systems (Hungary), Sedecal (Spain), MR Solutions (United Kingdom) and Cubresa (Canada) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Nuclear Medicine Preclinical Imaging Equipment market by , Application (Oncology, Cardiology, Neurology and Thyroid) and Region.



On the basis of geography, the market of Nuclear Medicine Preclinical Imaging Equipment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2021. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Diagnostics, the sub-segment i.e. SPECT [Standalone, SPECT/CT System, SPECT/MRI System] will boost the Nuclear Medicine Preclinical Imaging Equipment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Therapeutics, the sub-segment i.e. Alpha Emitters [RA-223, Others] will boost the Nuclear Medicine Preclinical Imaging Equipment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On 28th February 2019, Siemens Healthineers has announced that the new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been installed at the Hospital of the University of Pennsylvania (HUP) in Philadelphia – the first health care institution in the United States to install the technology.
On 14th September 2018, Bruker has announced the introduction of the new preclinical PET/CT Si78 scanner for whole-body molecular imaging at the World Molecular Imaging Congress. It combines Bruker's novel PET and outstanding micro-CT technologies in a single scanner operated by the multi-modality imaging software platform ParaVision™ 360.


Market Drivers
  • Growing Demand due to Shift From Standalone to Hybrid Modalities
  • Rising Incidences and Prevalence of Cancer

Opportunities
  • Rising Demand of Data Integrated Imaging Systems
  • The Increasing Demand From Emerging Market

Restraints
  • High Cost Associated with Nuclear Medicine Preclinical Imaging Equipment
  • Shorter Half-Life of Radiopharmaceuticals

Challenges
  • The Growing Adoption of Refurbished Diagnostic Systems


Key Target Audience
Nuclear Medicine Preclinical Imaging Equipment Manufactures, Nuclear Medicine Preclinical Imaging Equipment Suppliers, Nuclear Medicine Preclinical Imaging Equipment Distributors, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Application
  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
By Diagnostics
  • SPECT [Standalone, SPECT/CT System, SPECT/MRI System]
  • PET [Standalone, PET/CT System, PET/MRI System]
  • Trimodality (Spect/PET/CT) Systems

By Therapeutics
  • Alpha Emitters [RA-223, Others]
  • Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others]
  • Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others]

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand due to Shift From Standalone to Hybrid Modalities
      • 3.2.2. Rising Incidences and Prevalence of Cancer
    • 3.3. Market Challenges
      • 3.3.1. The Growing Adoption of Refurbished Diagnostic Systems
    • 3.4. Market Trends
      • 3.4.1. Growing Focus on Personalized Medicine
      • 3.4.2. The Increasing Expenditure Through Public-Private Partnerships to Modernize Diagnostic Imaging Centers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nuclear Medicine Preclinical Imaging Equipment, by Application, Diagnostics, Therapeutics and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Nuclear Medicine Preclinical Imaging Equipment (Value)
      • 5.2.1. Global Nuclear Medicine Preclinical Imaging Equipment by: Application (Value)
        • 5.2.1.1. Oncology
        • 5.2.1.2. Cardiology
        • 5.2.1.3. Neurology
        • 5.2.1.4. Thyroid
      • 5.2.2. Global Nuclear Medicine Preclinical Imaging Equipment by: Diagnostics (Value)
        • 5.2.2.1. SPECT [Standalone, SPECT/CT System, SPECT/MRI System]
        • 5.2.2.2. PET [Standalone, PET/CT System, PET/MRI System]
        • 5.2.2.3. Trimodality (Spect/PET/CT) Systems
      • 5.2.3. Global Nuclear Medicine Preclinical Imaging Equipment by: Therapeutics (Value)
        • 5.2.3.1. Alpha Emitters [RA-223, Others]
        • 5.2.3.2. Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others]
        • 5.2.3.3. Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others]
      • 5.2.4. Global Nuclear Medicine Preclinical Imaging Equipment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Nuclear Medicine Preclinical Imaging Equipment (Volume)
      • 5.3.1. Global Nuclear Medicine Preclinical Imaging Equipment by: Application (Volume)
        • 5.3.1.1. Oncology
        • 5.3.1.2. Cardiology
        • 5.3.1.3. Neurology
        • 5.3.1.4. Thyroid
      • 5.3.2. Global Nuclear Medicine Preclinical Imaging Equipment by: Diagnostics (Volume)
        • 5.3.2.1. SPECT [Standalone, SPECT/CT System, SPECT/MRI System]
        • 5.3.2.2. PET [Standalone, PET/CT System, PET/MRI System]
        • 5.3.2.3. Trimodality (Spect/PET/CT) Systems
      • 5.3.3. Global Nuclear Medicine Preclinical Imaging Equipment by: Therapeutics (Volume)
        • 5.3.3.1. Alpha Emitters [RA-223, Others]
        • 5.3.3.2. Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others]
        • 5.3.3.3. Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others]
      • 5.3.4. Global Nuclear Medicine Preclinical Imaging Equipment Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Nuclear Medicine Preclinical Imaging Equipment (Price)
  • 6. Nuclear Medicine Preclinical Imaging Equipment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bruker BioSpin (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Toshiba (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aspect Imaging (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Trifoil Imaging (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. MILabs (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mediso Medical Imaging Systems (Hungary)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sedecal (Spain)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. MR Solutions (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cubresa (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Nuclear Medicine Preclinical Imaging Equipment Sale, by Application, Diagnostics, Therapeutics and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Nuclear Medicine Preclinical Imaging Equipment (Value)
      • 7.2.1. Global Nuclear Medicine Preclinical Imaging Equipment by: Application (Value)
        • 7.2.1.1. Oncology
        • 7.2.1.2. Cardiology
        • 7.2.1.3. Neurology
        • 7.2.1.4. Thyroid
      • 7.2.2. Global Nuclear Medicine Preclinical Imaging Equipment by: Diagnostics (Value)
        • 7.2.2.1. SPECT [Standalone, SPECT/CT System, SPECT/MRI System]
        • 7.2.2.2. PET [Standalone, PET/CT System, PET/MRI System]
        • 7.2.2.3. Trimodality (Spect/PET/CT) Systems
      • 7.2.3. Global Nuclear Medicine Preclinical Imaging Equipment by: Therapeutics (Value)
        • 7.2.3.1. Alpha Emitters [RA-223, Others]
        • 7.2.3.2. Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others]
        • 7.2.3.3. Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others]
      • 7.2.4. Global Nuclear Medicine Preclinical Imaging Equipment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Nuclear Medicine Preclinical Imaging Equipment (Volume)
      • 7.3.1. Global Nuclear Medicine Preclinical Imaging Equipment by: Application (Volume)
        • 7.3.1.1. Oncology
        • 7.3.1.2. Cardiology
        • 7.3.1.3. Neurology
        • 7.3.1.4. Thyroid
      • 7.3.2. Global Nuclear Medicine Preclinical Imaging Equipment by: Diagnostics (Volume)
        • 7.3.2.1. SPECT [Standalone, SPECT/CT System, SPECT/MRI System]
        • 7.3.2.2. PET [Standalone, PET/CT System, PET/MRI System]
        • 7.3.2.3. Trimodality (Spect/PET/CT) Systems
      • 7.3.3. Global Nuclear Medicine Preclinical Imaging Equipment by: Therapeutics (Volume)
        • 7.3.3.1. Alpha Emitters [RA-223, Others]
        • 7.3.3.2. Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others]
        • 7.3.3.3. Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others]
      • 7.3.4. Global Nuclear Medicine Preclinical Imaging Equipment Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Nuclear Medicine Preclinical Imaging Equipment (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nuclear Medicine Preclinical Imaging Equipment: by Application(USD Million)
  • Table 2. Nuclear Medicine Preclinical Imaging Equipment Oncology , by Region USD Million (2016-2021)
  • Table 3. Nuclear Medicine Preclinical Imaging Equipment Cardiology , by Region USD Million (2016-2021)
  • Table 4. Nuclear Medicine Preclinical Imaging Equipment Neurology , by Region USD Million (2016-2021)
  • Table 5. Nuclear Medicine Preclinical Imaging Equipment Thyroid , by Region USD Million (2016-2021)
  • Table 6. Nuclear Medicine Preclinical Imaging Equipment: by Diagnostics(USD Million)
  • Table 7. Nuclear Medicine Preclinical Imaging Equipment SPECT [Standalone, SPECT/CT System, SPECT/MRI System] , by Region USD Million (2016-2021)
  • Table 8. Nuclear Medicine Preclinical Imaging Equipment PET [Standalone, PET/CT System, PET/MRI System] , by Region USD Million (2016-2021)
  • Table 9. Nuclear Medicine Preclinical Imaging Equipment Trimodality (Spect/PET/CT) Systems , by Region USD Million (2016-2021)
  • Table 10. Nuclear Medicine Preclinical Imaging Equipment: by Therapeutics(USD Million)
  • Table 11. Nuclear Medicine Preclinical Imaging Equipment Alpha Emitters [RA-223, Others] , by Region USD Million (2016-2021)
  • Table 12. Nuclear Medicine Preclinical Imaging Equipment Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others] , by Region USD Million (2016-2021)
  • Table 13. Nuclear Medicine Preclinical Imaging Equipment Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others] , by Region USD Million (2016-2021)
  • Table 14. South America Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2016-2021)
  • Table 15. South America Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 16. South America Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 17. South America Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 18. Brazil Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 19. Brazil Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 20. Brazil Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 21. Argentina Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 22. Argentina Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 23. Argentina Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 24. Rest of South America Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 25. Rest of South America Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 26. Rest of South America Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 27. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2016-2021)
  • Table 28. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 29. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 30. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 31. China Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 32. China Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 33. China Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 34. Japan Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 35. Japan Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 36. Japan Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 37. India Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 38. India Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 39. India Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 40. South Korea Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 41. South Korea Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 42. South Korea Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 43. Taiwan Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 44. Taiwan Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 45. Taiwan Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 46. Australia Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 47. Australia Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 48. Australia Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 52. Europe Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2016-2021)
  • Table 53. Europe Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 54. Europe Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 55. Europe Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 56. Germany Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 57. Germany Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 58. Germany Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 59. France Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 60. France Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 61. France Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 62. Italy Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 63. Italy Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 64. Italy Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 65. United Kingdom Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 66. United Kingdom Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 67. United Kingdom Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 68. Netherlands Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 69. Netherlands Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 70. Netherlands Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 71. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 72. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 73. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 74. MEA Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2016-2021)
  • Table 75. MEA Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 76. MEA Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 77. MEA Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 78. Middle East Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 79. Middle East Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 80. Middle East Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 81. Africa Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 82. Africa Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 83. Africa Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 84. North America Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2016-2021)
  • Table 85. North America Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 86. North America Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 87. North America Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 88. United States Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 89. United States Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 90. United States Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 91. Canada Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 92. Canada Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 93. Canada Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 94. Mexico Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2016-2021)
  • Table 95. Mexico Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2016-2021)
  • Table 96. Mexico Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2016-2021)
  • Table 97. Nuclear Medicine Preclinical Imaging Equipment Sales: by Application(K Units)
  • Table 98. Nuclear Medicine Preclinical Imaging Equipment Sales Oncology , by Region K Units (2016-2021)
  • Table 99. Nuclear Medicine Preclinical Imaging Equipment Sales Cardiology , by Region K Units (2016-2021)
  • Table 100. Nuclear Medicine Preclinical Imaging Equipment Sales Neurology , by Region K Units (2016-2021)
  • Table 101. Nuclear Medicine Preclinical Imaging Equipment Sales Thyroid , by Region K Units (2016-2021)
  • Table 102. Nuclear Medicine Preclinical Imaging Equipment Sales: by Diagnostics(K Units)
  • Table 103. Nuclear Medicine Preclinical Imaging Equipment Sales SPECT [Standalone, SPECT/CT System, SPECT/MRI System] , by Region K Units (2016-2021)
  • Table 104. Nuclear Medicine Preclinical Imaging Equipment Sales PET [Standalone, PET/CT System, PET/MRI System] , by Region K Units (2016-2021)
  • Table 105. Nuclear Medicine Preclinical Imaging Equipment Sales Trimodality (Spect/PET/CT) Systems , by Region K Units (2016-2021)
  • Table 106. Nuclear Medicine Preclinical Imaging Equipment Sales: by Therapeutics(K Units)
  • Table 107. Nuclear Medicine Preclinical Imaging Equipment Sales Alpha Emitters [RA-223, Others] , by Region K Units (2016-2021)
  • Table 108. Nuclear Medicine Preclinical Imaging Equipment Sales Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others] , by Region K Units (2016-2021)
  • Table 109. Nuclear Medicine Preclinical Imaging Equipment Sales Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others] , by Region K Units (2016-2021)
  • Table 110. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2016-2021)
  • Table 111. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 112. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 113. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 114. Brazil Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 115. Brazil Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 116. Brazil Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 117. Argentina Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 118. Argentina Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 119. Argentina Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 120. Rest of South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 121. Rest of South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 122. Rest of South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 123. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2016-2021)
  • Table 124. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 125. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 126. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 127. China Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 128. China Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 129. China Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 130. Japan Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 131. Japan Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 132. Japan Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 133. India Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 134. India Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 135. India Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 136. South Korea Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 137. South Korea Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 138. South Korea Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 139. Taiwan Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 140. Taiwan Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 141. Taiwan Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 142. Australia Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 143. Australia Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 144. Australia Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 145. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 146. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 147. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 148. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2016-2021)
  • Table 149. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 150. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 151. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 152. Germany Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 153. Germany Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 154. Germany Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 155. France Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 156. France Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 157. France Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 158. Italy Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 159. Italy Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 160. Italy Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 161. United Kingdom Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 162. United Kingdom Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 163. United Kingdom Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 164. Netherlands Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 165. Netherlands Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 166. Netherlands Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 167. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 168. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 169. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 170. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2016-2021)
  • Table 171. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 172. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 173. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 174. Middle East Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 175. Middle East Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 176. Middle East Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 177. Africa Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 178. Africa Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 179. Africa Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 180. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2016-2021)
  • Table 181. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 182. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 183. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 184. United States Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 185. United States Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 186. United States Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 187. Canada Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 188. Canada Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 189. Canada Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 190. Mexico Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2016-2021)
  • Table 191. Mexico Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2016-2021)
  • Table 192. Mexico Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2016-2021)
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Nuclear Medicine Preclinical Imaging Equipment: by Application(USD Million)
  • Table 204. Nuclear Medicine Preclinical Imaging Equipment Oncology , by Region USD Million (2022-2027)
  • Table 205. Nuclear Medicine Preclinical Imaging Equipment Cardiology , by Region USD Million (2022-2027)
  • Table 206. Nuclear Medicine Preclinical Imaging Equipment Neurology , by Region USD Million (2022-2027)
  • Table 207. Nuclear Medicine Preclinical Imaging Equipment Thyroid , by Region USD Million (2022-2027)
  • Table 208. Nuclear Medicine Preclinical Imaging Equipment: by Diagnostics(USD Million)
  • Table 209. Nuclear Medicine Preclinical Imaging Equipment SPECT [Standalone, SPECT/CT System, SPECT/MRI System] , by Region USD Million (2022-2027)
  • Table 210. Nuclear Medicine Preclinical Imaging Equipment PET [Standalone, PET/CT System, PET/MRI System] , by Region USD Million (2022-2027)
  • Table 211. Nuclear Medicine Preclinical Imaging Equipment Trimodality (Spect/PET/CT) Systems , by Region USD Million (2022-2027)
  • Table 212. Nuclear Medicine Preclinical Imaging Equipment: by Therapeutics(USD Million)
  • Table 213. Nuclear Medicine Preclinical Imaging Equipment Alpha Emitters [RA-223, Others] , by Region USD Million (2022-2027)
  • Table 214. Nuclear Medicine Preclinical Imaging Equipment Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others] , by Region USD Million (2022-2027)
  • Table 215. Nuclear Medicine Preclinical Imaging Equipment Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others] , by Region USD Million (2022-2027)
  • Table 216. South America Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2022-2027)
  • Table 217. South America Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 218. South America Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 219. South America Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 220. Brazil Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 221. Brazil Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 222. Brazil Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 223. Argentina Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 224. Argentina Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 225. Argentina Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 226. Rest of South America Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 227. Rest of South America Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 228. Rest of South America Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 229. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2022-2027)
  • Table 230. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 231. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 232. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 233. China Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 234. China Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 235. China Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 236. Japan Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 237. Japan Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 238. Japan Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 239. India Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 240. India Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 241. India Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 242. South Korea Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 243. South Korea Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 244. South Korea Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 245. Taiwan Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 246. Taiwan Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 247. Taiwan Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 248. Australia Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 249. Australia Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 250. Australia Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 251. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 252. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 253. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 254. Europe Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2022-2027)
  • Table 255. Europe Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 256. Europe Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 257. Europe Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 258. Germany Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 259. Germany Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 260. Germany Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 261. France Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 262. France Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 263. France Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 264. Italy Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 265. Italy Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 266. Italy Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 267. United Kingdom Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 268. United Kingdom Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 269. United Kingdom Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 270. Netherlands Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 271. Netherlands Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 272. Netherlands Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 273. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 274. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 275. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 276. MEA Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2022-2027)
  • Table 277. MEA Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 278. MEA Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 279. MEA Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 280. Middle East Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 281. Middle East Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 282. Middle East Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 283. Africa Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 284. Africa Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 285. Africa Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 286. North America Nuclear Medicine Preclinical Imaging Equipment, by Country USD Million (2022-2027)
  • Table 287. North America Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 288. North America Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 289. North America Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 290. United States Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 291. United States Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 292. United States Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 293. Canada Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 294. Canada Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 295. Canada Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 296. Mexico Nuclear Medicine Preclinical Imaging Equipment, by Application USD Million (2022-2027)
  • Table 297. Mexico Nuclear Medicine Preclinical Imaging Equipment, by Diagnostics USD Million (2022-2027)
  • Table 298. Mexico Nuclear Medicine Preclinical Imaging Equipment, by Therapeutics USD Million (2022-2027)
  • Table 299. Nuclear Medicine Preclinical Imaging Equipment Sales: by Application(K Units)
  • Table 300. Nuclear Medicine Preclinical Imaging Equipment Sales Oncology , by Region K Units (2022-2027)
  • Table 301. Nuclear Medicine Preclinical Imaging Equipment Sales Cardiology , by Region K Units (2022-2027)
  • Table 302. Nuclear Medicine Preclinical Imaging Equipment Sales Neurology , by Region K Units (2022-2027)
  • Table 303. Nuclear Medicine Preclinical Imaging Equipment Sales Thyroid , by Region K Units (2022-2027)
  • Table 304. Nuclear Medicine Preclinical Imaging Equipment Sales: by Diagnostics(K Units)
  • Table 305. Nuclear Medicine Preclinical Imaging Equipment Sales SPECT [Standalone, SPECT/CT System, SPECT/MRI System] , by Region K Units (2022-2027)
  • Table 306. Nuclear Medicine Preclinical Imaging Equipment Sales PET [Standalone, PET/CT System, PET/MRI System] , by Region K Units (2022-2027)
  • Table 307. Nuclear Medicine Preclinical Imaging Equipment Sales Trimodality (Spect/PET/CT) Systems , by Region K Units (2022-2027)
  • Table 308. Nuclear Medicine Preclinical Imaging Equipment Sales: by Therapeutics(K Units)
  • Table 309. Nuclear Medicine Preclinical Imaging Equipment Sales Alpha Emitters [RA-223, Others] , by Region K Units (2022-2027)
  • Table 310. Nuclear Medicine Preclinical Imaging Equipment Sales Beta Emitters [I-131, Y-90, SM-153, Re-186, Lu-117, Others] , by Region K Units (2022-2027)
  • Table 311. Nuclear Medicine Preclinical Imaging Equipment Sales Brachytherapy [Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others] , by Region K Units (2022-2027)
  • Table 312. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2022-2027)
  • Table 313. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 314. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 315. South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 316. Brazil Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 317. Brazil Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 318. Brazil Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 319. Argentina Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 320. Argentina Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 321. Argentina Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 322. Rest of South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 323. Rest of South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 324. Rest of South America Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 325. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2022-2027)
  • Table 326. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 327. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 328. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 329. China Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 330. China Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 331. China Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 332. Japan Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 333. Japan Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 334. Japan Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 335. India Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 336. India Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 337. India Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 338. South Korea Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 339. South Korea Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 340. South Korea Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 341. Taiwan Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 342. Taiwan Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 343. Taiwan Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 344. Australia Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 345. Australia Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 346. Australia Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 347. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 348. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 349. Rest of Asia-Pacific Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 350. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2022-2027)
  • Table 351. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 352. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 353. Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 354. Germany Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 355. Germany Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 356. Germany Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 357. France Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 358. France Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 359. France Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 360. Italy Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 361. Italy Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 362. Italy Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 363. United Kingdom Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 364. United Kingdom Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 365. United Kingdom Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 366. Netherlands Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 367. Netherlands Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 368. Netherlands Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 369. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 370. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 371. Rest of Europe Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 372. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2022-2027)
  • Table 373. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 374. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 375. MEA Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 376. Middle East Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 377. Middle East Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 378. Middle East Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 379. Africa Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 380. Africa Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 381. Africa Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 382. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Country K Units (2022-2027)
  • Table 383. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 384. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 385. North America Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 386. United States Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 387. United States Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 388. United States Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 389. Canada Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 390. Canada Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 391. Canada Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 392. Mexico Nuclear Medicine Preclinical Imaging Equipment Sales, by Application K Units (2022-2027)
  • Table 393. Mexico Nuclear Medicine Preclinical Imaging Equipment Sales, by Diagnostics K Units (2022-2027)
  • Table 394. Mexico Nuclear Medicine Preclinical Imaging Equipment Sales, by Therapeutics K Units (2022-2027)
  • Table 395. Research Programs/Design for This Report
  • Table 396. Key Data Information from Secondary Sources
  • Table 397. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nuclear Medicine Preclinical Imaging Equipment: by Application USD Million (2016-2021)
  • Figure 5. Global Nuclear Medicine Preclinical Imaging Equipment: by Diagnostics USD Million (2016-2021)
  • Figure 6. Global Nuclear Medicine Preclinical Imaging Equipment: by Therapeutics USD Million (2016-2021)
  • Figure 7. South America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 8. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 9. Europe Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 10. MEA Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 11. North America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 12. Global Nuclear Medicine Preclinical Imaging Equipment: by Application K Units (2016-2021)
  • Figure 13. Global Nuclear Medicine Preclinical Imaging Equipment: by Diagnostics K Units (2016-2021)
  • Figure 14. Global Nuclear Medicine Preclinical Imaging Equipment: by Therapeutics K Units (2016-2021)
  • Figure 15. South America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 16. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 17. Europe Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 18. MEA Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 19. North America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 20. Global Nuclear Medicine Preclinical Imaging Equipment share by Players 2021 (%)
  • Figure 21. Global Nuclear Medicine Preclinical Imaging Equipment share by Players (Top 3) 2021(%)
  • Figure 22. Global Nuclear Medicine Preclinical Imaging Equipment share by Players (Top 5) 2021(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Siemens AG (Germany) Revenue: by Geography 2021
  • Figure 26. Bruker BioSpin (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bruker BioSpin (United States) Revenue: by Geography 2021
  • Figure 28. Toshiba (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Toshiba (Japan) Revenue: by Geography 2021
  • Figure 30. Aspect Imaging (Israel) Revenue, Net Income and Gross profit
  • Figure 31. Aspect Imaging (Israel) Revenue: by Geography 2021
  • Figure 32. Trifoil Imaging (United States) Revenue, Net Income and Gross profit
  • Figure 33. Trifoil Imaging (United States) Revenue: by Geography 2021
  • Figure 34. MILabs (Netherlands) Revenue, Net Income and Gross profit
  • Figure 35. MILabs (Netherlands) Revenue: by Geography 2021
  • Figure 36. Mediso Medical Imaging Systems (Hungary) Revenue, Net Income and Gross profit
  • Figure 37. Mediso Medical Imaging Systems (Hungary) Revenue: by Geography 2021
  • Figure 38. Sedecal (Spain) Revenue, Net Income and Gross profit
  • Figure 39. Sedecal (Spain) Revenue: by Geography 2021
  • Figure 40. MR Solutions (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 41. MR Solutions (United Kingdom) Revenue: by Geography 2021
  • Figure 42. Cubresa (Canada) Revenue, Net Income and Gross profit
  • Figure 43. Cubresa (Canada) Revenue: by Geography 2021
  • Figure 44. Global Nuclear Medicine Preclinical Imaging Equipment: by Application USD Million (2022-2027)
  • Figure 45. Global Nuclear Medicine Preclinical Imaging Equipment: by Diagnostics USD Million (2022-2027)
  • Figure 46. Global Nuclear Medicine Preclinical Imaging Equipment: by Therapeutics USD Million (2022-2027)
  • Figure 47. South America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 48. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 49. Europe Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 50. MEA Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 51. North America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 52. Global Nuclear Medicine Preclinical Imaging Equipment: by Application K Units (2022-2027)
  • Figure 53. Global Nuclear Medicine Preclinical Imaging Equipment: by Diagnostics K Units (2022-2027)
  • Figure 54. Global Nuclear Medicine Preclinical Imaging Equipment: by Therapeutics K Units (2022-2027)
  • Figure 55. South America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 56. Asia Pacific Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 57. Europe Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 58. MEA Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
  • Figure 59. North America Nuclear Medicine Preclinical Imaging Equipment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Siemens AG (Germany)
  • Bruker BioSpin (United States)
  • Toshiba (Japan)
  • Aspect Imaging (Israel)
  • Trifoil Imaging (United States)
  • MILabs (Netherlands)
  • Mediso Medical Imaging Systems (Hungary)
  • Sedecal (Spain)
  • MR Solutions (United Kingdom)
  • Cubresa (Canada)
Select User Access Type

Key Highlights of Report


Jul 2022 164 Pages 52 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Nuclear Medicine Preclinical Imaging Equipment Market Quantitative research analysis
Global Nuclear Medicine Preclinical Imaging Equipment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Siemens AG (Germany), Bruker BioSpin (United States), Toshiba (Japan), Aspect Imaging (Israel), Trifoil Imaging (United States), MILabs (Netherlands), Mediso Medical Imaging Systems (Hungary), Sedecal (Spain), MR Solutions (United Kingdom) and Cubresa (Canada) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Focus on Personalized Medicine " is seen as one of major influencing trends for Nuclear Medicine Preclinical Imaging Equipment Market during projected period 2021-2027.
The Nuclear Medicine Preclinical Imaging Equipment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Nuclear Medicine Preclinical Imaging Equipment Market Report?

Have a Query? Click Here

Other Related Reports

Smart Home Healthcare Comprehensive Study by Application (Fall Prevention and Detection, Health Status Monitoring, Nutrition and Diet Monitoring, Memory Aids, Others), Technology (Wired, Wireless), S...
$ 3450
Preclinical Molecular Imaging Comprehensive Study by Type (Equipment/Device, Reagents and Imaging Agents, Service), Equipment Type (MRI, MPI, Ultrasound, Preclinical Nuclear Imaging Systems (SPECT, ...
$ 3750
Chemotherapy Comprehensive Study by Type (Alkylating Agents, Anti-metabolites, Plant Alkaloids and Terpenoids, Podophyllotoxin, Taxanes, Topoisomerase Inhibitor, Anti-Tumour Antibiotics, Hormones, Mo...
$ 3750
Prostate Cancer Nuclear Medicine Diagnostics Comprehensive Study by Type (Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET)), Application (Hospitals, Clinics, Oth...
$ 3800
Smart Medicine Bottles Comprehensive Study by Type (Smart Pill Boxes, Smart Pill Bottles, Others), Indication (Dementia, Cancer Management, Diabetes Care, Others), End Use (Home Care Settings, Specia...
$ 3450
Home Health Hub Comprehensive Study by Type (Standalone Hubs, Smartphone-based hubs, Services (Remote Patient Monitoring Services, Support & Maintenance Services)), Patient Monitoring (High-acuity Pa...
$ 3750